Eighteen cases exposed to Sarin in Matsumoto, Japan

Internal Medicine

Volumn 36, Issue 7, 1997, Pages 466-470

  Suzuki, Jun ^a   Kohno, Tsunesuke ^a   Tsukagosi, Masaki ^a   Furuhata, Toshihiko ^a   Yamazaki, Kyouhei ^a  

^a Matsumoto Kyoritsu Hospital   (Japan)

Author keywords

Cholinesterase inhibitor; Direct hemoperfusion; Plasma cholinesterase

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; SARIN; TOXIC GAS;

AKINETIC MUTISM; ARTICLE; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL FEATURE; ENZYME ACTIVITY; HEMOPERFUSION; HUMAN; HYPOCAPNIA; HYPOKALEMIA; INTOXICATION; JAPAN; NEUROTOXICITY;

EID: 0030840741     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.36.466     Document Type: Article

References (7)

1. Macilwian C. Study proves Iraq used nerve gas, Nature 363: 3, 1993 (news).
2. Taylor P. Anticholinesterase agents. in: Pharmacological Basis of Therapeutics, Goodman LS, and Gilman A. Eds, p. 161, 1996.
3. Roy H. Accidental exposure to sarin: Vision effects. Arch Toxicol 56: 201, 1985.
4. Duffy FH, Burchfiel JL, Bartels PH, Gaon M. Sim VM. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol Appl Pharmacol 47: 161, 1979.
5. Minton NA, Murray VS. A review of arganophosphate poisoning. Med Toxicol Adverse Drug Exp 3: 350, 1988.
6. Morita H, Yanagisawa N, Nakajima T, et al. Sarin poisoning in Matsumoto, Japan. Lancet 346: 290, 1995 (see comments).
7. Singer AW, Jaax NK, Graham JS, McLeod CG Jr. Cardiomyopathy in soman sarin intoxicated rats. Toxicol Lett 36: 243, 1987.